ID

13604

Description

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00513305

Link

https://clinicaltrials.gov/show/NCT00513305

Keywords

Versions (1)
  1. 2/19/16 2/19/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

February 19, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Acute Myeloid Leukemia NCT00513305

English

Eligibility Acute Myeloid Leukemia NCT00513305

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient has confirmed acute myeloid leukemia (aml).
Description

the patient has confirmed acute myeloid leukemia (aml).

Data type

boolean

Alias
UMLS CUI [1]
C0023467
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
Description

the patient is unwilling or unable to tolerate conventional induction chemotherapy.

Data type

boolean

Alias
UMLS CUI [1]
C0392920
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
Description

the patient has no comorbid conditions that would limit life expectancy to less than 3 months.

Data type

boolean

Alias
UMLS CUI [1]
C0023671
patient must meet specific laboratory parameters for study inclusion.
Description

patient must meet specific laboratory parameters for study inclusion.

Data type

boolean

Alias
UMLS CUI [1]
C0022885
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
Description

the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205156
previous treatment with low-dose cytarabine is not permitted.
Description

previous treatment with low-dose cytarabine is not permitted.

Data type

boolean

Alias
UMLS CUI [1]
C0010711
the patient has a qt interval outside of the protocol-specified range.
Description

the patient has a qt interval outside of the protocol-specified range.

Data type

boolean

Alias
UMLS CUI [1]
C0429028
the patient has laboratory values outside of protocol-specified ranges.
Description

the patient has laboratory values outside of protocol-specified ranges.

Data type

boolean

Alias
UMLS CUI [1]
C0022885
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Description

the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.

Data type

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C0851346
UMLS CUI [3]
C1875319
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
Description

the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.

Data type

boolean

Alias
UMLS CUI [1]
C0009488
the patient has known central nervous system involvement with aml.
Description

the patient has known central nervous system involvement with aml.

Data type

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0449389
Back to the top of the page

Similar models

Eligibility Acute Myeloid Leukemia NCT00513305

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
acute myeloid leukemia
Item
the patient has confirmed acute myeloid leukemia (aml).
boolean
C0023467 (UMLS CUI [1])
conventional induction chemotherapy
Item
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
boolean
C0392920 (UMLS CUI [1])
life expectancy
Item
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
boolean
C0023671 (UMLS CUI [1])
laboratory parameters
Item
patient must meet specific laboratory parameters for study inclusion.
boolean
C0022885 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy
Item
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
boolean
C0392920 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
cytarabine
Item
previous treatment with low-dose cytarabine is not permitted.
boolean
C0010711 (UMLS CUI [1])
qt interval
Item
the patient has a qt interval outside of the protocol-specified range.
boolean
C0429028 (UMLS CUI [1])
laboratory values
Item
the patient has laboratory values outside of protocol-specified ranges.
boolean
C0022885 (UMLS CUI [1])
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Item
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
boolean
C0677881 (UMLS CUI [1])
C0851346 (UMLS CUI [2])
C1875319 (UMLS CUI [3])
comorbidity
Item
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
boolean
C0009488 (UMLS CUI [1])
central nervous system involvement
Item
the patient has known central nervous system involvement with aml.
boolean
C0023467 (UMLS CUI [1,1])
C0449389 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial